Metoclopramide Noridem

Metoclopramide Hydrochloride Monohydrate, the active ingredient in Metoclopramide Noridem, is a dopamine D2 receptor antagonist presented as a sterile injectable solution for intramuscular and intravenous use. It treats nausea and vomiting, gastroparesis, and helps prevent chemotherapy‑induced nausea in adult patients.

GNH USA supplies Metoclopramide Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide is used to manage disorders of the gastrointestinal tract and nausea pathways. - Nausea and vomiting: Reduces acute and delayed nausea and vomiting associated with various causes, including postoperative and chemotherapy settings. - Gastroparesis: Improves gastric emptying and alleviates symptoms such as early satiety and bloating in patients with delayed gastric motility. - Chemotherapy‑induced nausea: Prevents and treats nausea and vomiting caused by cytotoxic cancer therapies in adult patients.

Metoclopramide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Drowsiness: feeling of sleepiness or reduced alertness. - Fatigue: general sense of tiredness. - Restlessness: inner sense of unease or agitation. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Tardive dyskinesia: persistent involuntary movements, potentially irreversible. - Neuroleptic malignant syndrome: life‑threatening reaction with fever, muscle rigidity, and autonomic instability.

When prescribing Metoclopramide, clinicians should consider several safety measures. - Assess neurological status: monitor for extrapyramidal symptoms, especially in the elderly. - Use with caution in renal impairment: dose adjustment may be required. - Avoid in patients with known hypersensitivity to metoclopramide or its excipients. - Review concomitant CNS depressants: may enhance sedation or respiratory depression. - Limit duration: prolonged use increases risk of tardive dyskinesia. - Store at ambient temperature: keep in the original packaging, protect from moisture and light.

Metoclopramide can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Antipsychotics (e.g., haloperidol): additive dopamine antagonism may worsen extrapyramidal effects. - MAO inhibitors: risk of hypertensive crisis and serotonin syndrome. - CNS depressants (opioids, benzodiazepines): enhanced sedation and respiratory depression. - QT‑prolonging agents (e.g., ondansetron): increased risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - SSRIs and SNRIs: potential for serotonin syndrome. - Digoxin: metoclopramide can raise serum digoxin levels. - Insulin or oral hypoglycemics: may potentiate hypoglycemia.